Aura Biosciences (AURA) Assets Average (2021 - 2026)

Aura Biosciences' Assets Average history runs 6 years deep, the most recent figure standing at $153.6 million for Q1 2026.

• Quarterly Assets Average fell 9.11% year-over-year to $153.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.6 million (down 9.11% YoY) and the FY2025 annual result came in at $176.0 million, down 19.57% from the prior year.
• Assets Average was $153.6 million for Q1 2026 at Aura Biosciences, down from $179.7 million in the prior quarter.
• Across five years, Assets Average topped out at $245.0 million in Q1 2024 and bottomed at $139.1 million in Q3 2022.
• A 5-year average of $187.7 million and a median of $186.3 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average soared 46.4% — and 2025, when it sank 31.05%.
• Aura Biosciences' Assets Average stood at $183.5 million in 2022, then grew by 18.46% to $217.4 million in 2023, then decreased by 10.81% to $193.9 million in 2024, then dropped by 7.32% to $179.7 million in 2025, then dropped by 14.56% to $153.6 million in 2026.
• Business Quant data shows AURA's Assets Average at $153.6 million in Q1 2026, $179.7 million in Q4 2025, and $197.2 million in Q3 2025.